State Ledger
Company profile

Decoy Therapeutics Inc. CIK 1615219

Ticker
DCOY (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Houston, TX 77021
Fiscal year end
2025 (FY)
Market Data
Close
$1.26
Change
-$0.21
Change %
-14.29%
Volume
904

DCOY · trading date Oct 13, 2026 · previous close $1.47 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$12.52M
Total assets
$11.06M
Total liabilities
$5.17M
Stockholders' equity
$5.89M
Cash & equivalents
$10.71M
Operating income
-$12.61M
Operating cash flow
-$4.83M
Capital expenditures
$577.0K

Fiscal year 2025, via 10-K filed 2026-03-31. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$5.40M
Free cash flow margin
—
Liabilities / assets
46.7%
Equity / assets
53.3%
CapEx / revenue
—
Operating cash flow / net income
0.39×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$12.52M $11.06M $5.17M $5.89M
2024 — -$5.58M $3.02M $1.51M $1.51M
2023 — -$12.54M $6.59M $1.30M $5.29M
2022 $0 -$31.61M $14.65M $4.27M $10.38M
2021 $1.84M -$12.77M $40.83M $2.11M $38.72M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-09-15
Financials filed via
Form 10-K
filed 2026-03-31

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Houston, TX 77021
2450 HOLCOMBE BLVD
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:57 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Texas — Public Companies